Zobrazeno 241 - 250
of 2 774
pro vyhledávání: '"Deepak L Bhatt"'
Autor:
Emily C. O'Brien, Jingjing Wu, Xin Zhao, Phillip J. Schulte, Gregg C. Fonarow, Adrian F. Hernandez, Lee H. Schwamm, Eric D. Peterson, Deepak L. Bhatt, Eric E. Smith
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)
BackgroundHealthcare resources vary geographically, but associations between hospital‐based resources and acute stroke quality and outcomes remain unclear. Methods and ResultsUsing Get With The Guidelines‐Stroke and Dartmouth Atlas of Health Care
Externí odkaz:
https://doaj.org/article/b7e04452091040e7a152da635cd9cb83
Autor:
Lauren G. Gilstrap, Gregg C. Fonarow, Akshay S. Desai, Li Liang, Roland Matsouaka, Adam D. DeVore, Eric E. Smith, Paul Heidenreich, Adrian F. Hernandez, Clyde W. Yancy, Deepak L. Bhatt
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)
BackgroundGuidelines recommend continuation or initiation of guideline‐directed medical therapy, including angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (ACEi/ARB), in hospitalized patients with heart failure with redu
Externí odkaz:
https://doaj.org/article/c7097e5976b34b35a37a0ec8e9cc33ef
Autor:
Patrick Heindel, Jessica Feliz, Dirk Hentschel, Mohammed Al-Omran, Steven Burke, Deepak L. Bhatt, Michael Belkin, C. Keith Ozaki, Mohamad A. Hussain
Publikováno v:
Journal of Vascular Surgery. 76:e91-e92
Autor:
Lauren, Gilstrap, Nicole, Solomon, Karen, Chiswell, A, James O'Malley, Jonathan S, Skinner, Gregg C, Fonarow, Deepak L, Bhatt, Clyde W, Yancy, Adam D, DeVore
Publikováno v:
Journal of cardiac failure.
Beta-blockers (BB) and renin angiotensin system inhibitors (RASi) are foundational for the treatment of heart failure with reduced ejection fraction (HFrEF). However, given the increased risk of side effects in older patients, uncertainly remains as
Autor:
Tobias, Tritschler, Anuj, Patel, Noémie, Kraaijpoel, Deepak L, Bhatt, Giuseppe, De Luca, Pietro, Di Santo, Fausto, Feres, Ricardo A, Costa, Benjamin, Hibbert, Takaaki, Isshiki, Grégoire, Le Gal, Lana A, Castellucci
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(7)
Assessment of the case-fatality rate (CFR) of major bleeding on dual antiplatelet therapy (DAPT) may improve balancing risks and benefits of different durations of DAPT following percutaneous coronary intervention (PCI).To determine the CFR of major
Autor:
Avnish Tripathi, Paul S. Chan, Mazen S. Albaghdadi, Mohammad Saud Khan, Varunsiri Atti, Arti Saraswat, Glenn A. Hirsch, Sammy Elmariah, Douglas E. Drachman, Deepak L. Bhatt
Publikováno v:
JACC. Cardiovascular interventions. 15(24)
In-hospital cardiac arrest during cardiac catheterization is not uncommon. The extent of variation in survival after cardiac arrest occurring in the cardiac catheterization laboratory (CCL) and underlying factors are not well known.The aim of this st
Autor:
Josephine Harrington, Jacob A. Udell, W. Schuyler Jones, Stefan D. Anker, Deepak L. Bhatt, Mark C. Petrie, Ola Vedin, Mikhail Sumin, Isabella Zwiener, Adrian F. Hernandez, Javed Butler
Background\ud : Patients with acute myocardial infarction (MI) are at risk for developing heart failure (HF) and subsequently are at an increased risk of mortality. Sodium-glucose cotransporter-2 inhibitors have been proven to improve outcomes in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79e595dc72fc1b205ca609c27e4bea50
https://eprints.gla.ac.uk/271326/2/271326.pdf
https://eprints.gla.ac.uk/271326/2/271326.pdf
Autor:
Davide, Capodanno, Usman, Baber, Deepak L, Bhatt, Jean-Philippe, Collet, George, Dangas, Francesco, Franchi, C Michael, Gibson, Hyeon-Cheol, Gwon, Adnan, Kastrati, Takeshi, Kimura, Pedro A, Lemos, Renato D, Lopes, Roxana, Mehran, Michelle L, O'Donoghue, Sunil V, Rao, Fabiana, Rollini, Patrick W, Serruys, Philippe G, Steg, Robert F, Storey, Marco, Valgimigli, Pascal, Vranckx, Hirotoshi, Watanabe, Stephan, Windecker, Dominick J, Angiolillo
Publikováno v:
Nature reviews. Cardiology. 19(12)
For 20 years, dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a platelet P2Y
Autor:
Remo H.M. Furtado, Itamar Raz, Erica L. Goodrich, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Philip Aylward, Anthony J Dalby, Mikael Dellborg, Doina Dimulescu, José C. Nicolau, Anthonius J.M. Oude Ophuis, Avivit Cahn, Ofri Mosenzon, Ingrid Gause-Nilsson, Anna Maria Langkilde, Marc S. Sabatine, Stephen D. Wiviott
Publikováno v:
CIRCULATION
Background: Dapagliflozin improved heart failure and kidney outcomes in patients with type 2 diabetes (T2DM) with or at high risk for atherosclerotic cardiovascular disease in the DECLARE-TIMI 58 trial (Dapagliflozin Effect on Cardiovascular Events
Autor:
Catherine G Derington, Adam P Bress, Jennifer S Herrick, WENJUN FAN, Nathan D Wong, Katherine E Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao, Deepak L Bhatt, William S Weintraub
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 15
Background: To estimate the population health impact of treating all US adults eligible for the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT) with icosapent ethyl (IPE), we estimated (1) the number of ASCVD ev